Back to Journals » Cancer Management and Research » Volume 10

Prognostic significance of leukopenia during the induction phase in adult B cell acute lymphoblastic leukemia

Authors Xing C, Liang B, Wu J, Yang Q, Hu G, Yan Y, Zhang Y, Jiang S, Yu K, Feng J

Received 29 November 2017

Accepted for publication 12 February 2018

Published 28 March 2018 Volume 2018:10 Pages 625—635


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Kenan Onel

Chongyun Xing,1,* Bin Liang,1,* Junqing Wu,1 Qianqian Yang,1 Gang Hu,1 Ye Yan,1 Yu Zhang,1 Songfu Jiang,1 Kang Yu,1 Jianhua Feng1,2

1Division of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, PR China; 2Division of Pediatric Hematology-Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, PR China

*These authors contributed equally to this work

Abstract: The association between chemotherapy-induced leukopenia and clinical outcome has been reported for several types of cancer. The objective of the current study was to evaluate the association of chemotherapy-induced leukopenia during the induction phase with the clinical outcome of adult B cell acute lymphoblastic leukemia (B-ALL). Fifty-one cases of B-ALL, age ≥14 years, were reviewed. The variables under consideration included age, sex, the initial white blood cell (WBC) count (WBC-0), as well as the WBC counts on days 8 (WBC-8), 15 (WBC-15), and 22 (WBC-22) during induction therapy, early bone marrow responses on day 15 during induction therapy, immunophenotype, and cytogenetics. Univariate analysis revealed that WBC-15 ≥0.40×109/L was significantly associated with inferior event-free survival (EFS) (hazard ratio [HR]=2.95, P=0.004) and overall survival (OS) (HR=2.92, P=0.015). On multivariate analysis, high WBC-15 (≥0.40×109/L) remained an independent prognostic factor for EFS (HR=3.29, P=0.014) and OS (HR=3.29, P=0.038). Our results suggested that WBC-15 may contribute to refinements in the current risk stratification algorithms for adult B-ALL.

Keywords: adult acute lymphoblastic leukemia, chemotherapy, white blood cell count, prognosis, survival

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]